期刊文献+

遗传性凝血因子V缺陷症的实验室诊断 被引量:3

Laboratory diagnosis of a pedigree with congenital coagulation factor V deficiency
原文传递
导出
摘要 目的 探讨遗传性凝血因子V(FV)缺陷症家系的实验室诊断和分子发病机制。方法 对 1个FⅤ缺陷症家系进行研究。采用活化部分凝血活酶时间 (APTT) ,凝血酶原时间 (PT)及FV促凝活性 (FV :C)和FV抗原 (FV :Ag)测定进行表型诊断 ;用PCR法对先证者FV基因 2 5个外显子及其侧翼序列进行扩增 ,PCR产物纯化后直接测序 ,检测其基因突变。通过cDNA测序分析剪切位点突变引起编码序列的变化。结果 先证者APTT 12 3s ,PT 4 3 4s ,FV :C 1 6 % ,FV :Ag 7 2 %。基因分析发现 ,先证者第 8内含子受点发生AG→GG突变 ;cDNA分析发现 ,该突变导致剪切位点前移 2 4bp ,即在编码序列中 ,于第 8外显子和第 9外显子间插入了 2 4bp ,插入序列未引起读码框架漂移 ,使编码的FV蛋白插入了 8个氨基酸。结论 先证者为I型遗传性FV缺陷症 ,第 8内含子 3′端剪切位点突变 ,引起编码序列 2 4bp插入是导致该例先证者发生FV缺陷症的分子机制。 Objective To study on the laboratory diagnosis and molecular mechanism of a pedigree with inherited factor V deficiency. Methods The tests of activated partial thromboplastin time (APTT),prothrombin time (PT), FV activity (FV:C) and FV antigen were adopted for phenotype diagnosis. The genomic DNA was extracted from the peripheral blood of the propositus. 25 exons and their flanks of FV gene were amplified by polymerase chain reaction. The PCR products were screened by direct sequencing. The cDNA sequencing was performed to analyze the change of FV coding sequence by splice site mutation. Results APTT,PT,FV: C, FV: Ag of the propositus were 123 s, 43.4 s, 1.6% and 7.2%, respectively. Homozygous mutation AG→GG of intron 8 was found at 3' splice site in the propositus, where the 3' splice site was moved 24 bp ahead. 24 bp nucleotides insertion between exon 8 and exon 9 were detected by FV cDNA sequencing, where the insertion sequence did not cause frameshift. 8 aa was inserted between 404 and 405 sites of the amino acid sequence of mutated FV protein. Conclusion The proband was diagnosed with type I inherited coagulation factorV deficiency. Homozygous splice site mutation causing 24 bp insertion in FV cDNA was the molecular mechanism of this pedigree.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2004年第2期93-96,共4页 Chinese Journal of Laboratory Medicine
关键词 遗传性凝血因子V缺陷症 实验室诊断 分子发病机制 凝血活酶时间 凝血酶原时间 Coagulation factor V Hereditary diseases Autosme abormalities
  • 相关文献

参考文献3

二级参考文献18

  • 1乐玮,于金德,陆林,陶蓉,尤蓓,蔡煦,曹文俊,黄薇,何汝敏,陈竺,龚兰生.Arg485Lys polymorphism of factor Ⅴ increases the risk of coronary artery disease in a Chinese population[J].Chinese Medical Journal,2000(11):3-6. 被引量:3
  • 2Jenny RJ, Pittman DD, Toole JJ. et al. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci U S A,1987,4:4846-4850.
  • 3van Wijk R, Nieuwenhuis K, van den Berg M, et al. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood,2001,98:358-367.
  • 4Guasch JF, Cannegieter S, Reitsma PH. et al. Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene. Br J Haematol,1998,101:32-39.
  • 5Guasch JF, Lensen RP, Bertina RM.Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance. Thromb Haemost,1997,77:252-257.
  • 6Murray JM, Rand MD, Egan JO. et al. Factor V New Brunswick: Ala221-to-Val substitution results in reduced cofactor activity.Blood,1995,86:1820-1827.
  • 7Castoldi E, Kalafatis M, Lunghi B. et al. Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma. Thromb Haemost,1998,80:403-406.
  • 8Mirochnik O, Halim-Kertanegara N, Henniker AJ, et al. A novel factor V null mutation at Arg 506 causes a false positive factor V Leiden result. Thromb Haemost,1999,82:1198-1199.
  • 9Zehnder JL, Hiraki DD, Jones CD, et al. Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford. Thromb Haemost,1999,82:1097-1099.
  • 10Castoldi E, Simioni P, Kalafatis M, et al. Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood, 2000,96:1443-1448.

共引文献21

同被引文献42

  • 1Van Wijk R, Nieuwenhuis K, Vanden M, et al. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood, 2001, 98:358-367.
  • 2Chen TY, Lin TM, Chen HY,et al. Gly392Cys missense mutation in the A2 domain of factor V causing severe factor V deficiency:molecular characterization by expression of the recombinant protein. Thromb Haemost, 2005,93(3):614-615.
  • 3Seanavini D, Girelli D, Lunghi B,et al. Modulation of factor V levels in plasma by polymorphisms in the C2 domain. Arterioscler Thromb Vase Biol, 2004,24(1):200-206.
  • 4Soria JM, Blangero J, Souto JC, et al. Identification of a large deletion and three novel mutations in exon 13 of the factor V gene in a Spanish family with normal factor V coagulant and anticoagulant properties. Hum Genet, 2002,111:59-65.
  • 5Montefusco MC, Duga S, Asselta R, et al. A novel two base pair deletion in the factor V gene associated with severe factor V deficiency. Br J Haematol,2000,111:1240-1246.
  • 6Schrijver I, Hong DW, Mandle L, et al, High frequency of premature termination mutations in the factor V gene: three factor V deficiency case reports and a mutation review. Thromb Haemost,2005,g3(3) :610-611.
  • 7Schrijver I, Koerper MA, Jones CD, et al, Homozygous factor V splice site mutation associated with severe factor V deficiency.Blood, 2002,99 : 3063-3065.
  • 8Asselta R, Montefusco MC, Duga S , et al. Severe factor V deficiency: exon skipping in the factor V gene causing a partial deletion of the C1 domain. J Thromb Haemost, 2003,1:1237-1244.
  • 9Asselta R, Tenchini ML, Holme R, et al. The discovery of Mary's mutation. J Thromb Haemost,2003,1 : 397-398.
  • 10Steen M, Miteva M, Villoutreix BO , et al. Factor V New Brunswick:Ala221Val associated with F V deficiency reproduced in vitro and functionally characterized. Blood, 2003,102:1316-1322.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部